A Phase 1/2, Placebo-Controlled, Randomized, Observer-Blind, Dose-Finding, First-In-Human Study to Describe the Safety, Tolerability, And Immunogenicity of an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine In Healthy Older Adults

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/44156/MonH-2018-150980(v1)
NMA SSA Reference Number: SSA/44156/MonH-2019-166766(v1)
ERM Project Code: 44156
Monash Health Ref: RES-18-0000-515A
Effective start/end date28/03/1927/03/24


  • clinical trial
  • phase 1 and 2 study
  • vaccines